Bright Minds Biosciences (DRUG) Current Assets (2020 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Current Assets came in at $227.7 million in Q1 2026, up 480.24% YoY from $39.2 million in Q1 2025, and up 249.8% on a QoQ basis from $65.1 million in Q4 2025.
Bright Minds Biosciences (DRUG) Current Assets (2020 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 7 years of Current Assets data on file, last reported at $227.7 million in Q1 2026.
- Quarterly Current Assets rose 480.24% year-over-year to $227.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $227.7 million (up 480.24% YoY) and the FY2025 annual result came in at $61.3 million, up 1295.89% from the prior year.
- Current Assets climbed to $227.7 million in Q1 2026, from $65.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $227.7 million in Q1 2026 to a low of $4.4 million in Q3 2024.
- A 5-year average of $35.2 million and a median of $8.4 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets slumped 44.53% — and 2025, when it jumped 1295.89%.
- Tracing DRUG's Current Assets over 5 years: stood at $8.4 million in 2022, then tumbled by 40.34% to $5.0 million in 2023, then soared by 729.69% to $41.7 million in 2024, then jumped by 56.2% to $65.1 million in 2025, then jumped by 249.8% to $227.7 million in 2026.
- The last three Current Assets figures came in at $227.7 million (Q1 2026), $65.1 million (Q4 2025), and $61.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Bright Minds Biosciences | 733.05 Mn | 733.05 Mn | - | 227.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.73 Mn |
| Dec 31, 2025 | 65.10 Mn |
| Sep 30, 2025 | 61.26 Mn |
| Jun 30, 2025 | 37.80 Mn |
| Mar 31, 2025 | 39.25 Mn |
| Dec 31, 2024 | 41.68 Mn |
| Sep 30, 2024 | 4.39 Mn |
| Jun 30, 2024 | 4.58 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | 5.02 Mn |
| Sep 30, 2023 | 5.08 Mn |
| Jun 30, 2023 | 6.24 Mn |
| Mar 31, 2023 | 7.31 Mn |
| Dec 31, 2022 | 8.42 Mn |
| Sep 30, 2022 | 9.16 Mn |
| Sep 30, 2021 | 15.92 Mn |
| Sep 30, 2020 | 659,034.07 |